<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The lymphoid follicle is a specialized microenvironment for the differentiation of antigen (Ag)-activated B cells; the major stromal cell components in lymphoid follicle are the follicular dendritic cells (<z:chebi fb="17" ids="38848">FDCs</z:chebi>) </plain></SENT>
<SENT sid="1" pm="."><plain>At the same time, most of the B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> originate from the germinal center, and the generation and blast transformation of B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> occurs in close association with <z:chebi fb="17" ids="38848">FDCs</z:chebi> in the early stage of <z:mp ids='MP_0002006'>tumorigenesis</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>To study the functional roles of <z:chebi fb="17" ids="38848">FDCs</z:chebi> in <z:e sem="disease" ids="C0598766" disease_type="Neoplastic Process" abbrv="">lymphomagenesis</z:e>, we established an inducible <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> model </plain></SENT>
<SENT sid="3" pm="."><plain>The human B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cell line, L3055, formed <z:e sem="disease" ids="C0280100" disease_type="Neoplastic Process" abbrv="">solid tumors</z:e> only when inoculated with an <z:chebi fb="17" ids="38848">FDC</z:chebi> line, HK </plain></SENT>
<SENT sid="4" pm="."><plain>In addition, 2 FDC-signaling molecules (<z:chebi fb="17" ids="38848">FDC</z:chebi>-SMs), a novel protein 8D6 and 4G10/CD44, are required for <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> formation in vivo, because monoclonal antibodies (mAbs) specific to these 2 proteins inhibited <z:e sem="disease" ids="C0598766" disease_type="Neoplastic Process" abbrv="">lymphomagenesis</z:e> completely when they were inoculated with L3055 and HK cells </plain></SENT>
<SENT sid="5" pm="."><plain>However, these 2 FDC-SMs have distinct functional roles in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> formation </plain></SENT>
<SENT sid="6" pm="."><plain><z:chebi fb="17" ids="38848">FDC</z:chebi>-SM-8D6 enhances L3055 cell proliferation, whereas <z:chebi fb="17" ids="38848">FDC</z:chebi>-SM-4G10/CD44 inhibits its <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="7" pm="."><plain>Identification of the functional roles of these critical <z:chebi fb="17" ids="38848">FDC</z:chebi>-SMs may lead to the discovery of therapeutic drugs that suppress the survival and growth of <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells </plain></SENT>
</text></document>